{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T05:49:51Z","timestamp":1795067391043,"version":"4.10.2"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mutations in SNCA, the gene encoding \u03b1-synuclein (\u03b1Syn), cause familial Parkinson\u2019s disease (PD) and aberrant \u03b1Syn is a key pathological hallmark of idiopathic PD. This \u03b1-synucleinopathy leads to mitochondrial dysfunction, which may drive dopaminergic neurodegeneration. PARKIN and PINK1, mutated in autosomal recessive PD, regulate the preferential autophagic clearance of dysfunctional mitochondria (\u201cmitophagy\u201d) by inducing ubiquitylation of mitochondrial proteins, a process counteracted by deubiquitylation via USP30. Here we show that loss of USP30 in\n                    <jats:italic>Usp30<\/jats:italic>\n                    knockout mice protects against behavioral deficits and leads to increased mitophagy, decreased phospho-S129 \u03b1Syn, and attenuation of SN dopaminergic neuronal loss induced by \u03b1Syn. These observations were recapitulated with a potent, selective, brain-penetrant USP30 inhibitor, MTX115325, with good drug-like properties. These data strongly support further study of USP30 inhibition as a potential disease-modifying therapy for PD.\n                  <\/jats:p>","DOI":"10.1038\/s41467-023-42876-1","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T06:01:44Z","timestamp":1699855304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson\u2019s disease mouse model"],"prefix":"10.1038","volume":"14","author":[{"given":"Tracy-Shi Zhang","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5356-3048","authenticated-orcid":false,"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6391-2037","authenticated-orcid":false,"given":"Simona","family":"Eleuteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Luckhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Almond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7574-4643","authenticated-orcid":false,"given":"Laura","family":"Burzynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8423-029X","authenticated-orcid":false,"given":"N\u00f3ra M.","family":"M\u00e1rkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Lelliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha A.","family":"Karp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9490-0306","authenticated-orcid":false,"given":"David J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9317-7937","authenticated-orcid":false,"given":"Stephen P.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Feng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1481-9407","authenticated-orcid":false,"given":"Ian G.","family":"Ganley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2872-4468","authenticated-orcid":false,"given":"Gabriel","family":"Balmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4793-0574","authenticated-orcid":false,"given":"David K.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"42876_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/bph.15684","volume":"179","author":"ME Haque","year":"2022","unstructured":"Haque, M. E. et al. Targeting alpha-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson\u2019s disease. Br. J. Pharm. 179, 23\u201345 (2022).","journal-title":"Br. J. Pharm."},{"key":"42876_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/jnc.15154","volume":"156","author":"D Trinh","year":"2021","unstructured":"Trinh, D., Israwi, A. R., Arathoon, L. R., Gleave, J. A. & Nash, J. E. The multi-faceted role of mitochondria in the pathology of Parkinson\u2019s disease. J. Neurochem 156, 715\u2013752 (2021).","journal-title":"J. Neurochem"},{"key":"42876_CR3","doi-asserted-by":"publisher","first-page":"105056","DOI":"10.1016\/j.nbd.2020.105056","volume":"145","author":"G Cutillo","year":"2020","unstructured":"Cutillo, G., Simon, D. K. & Eleuteri, S. VPS35 and the mitochondria: Connecting the dots in Parkinson\u2019s disease pathophysiology. Neurobiol. Dis. 145, 105056 (2020).","journal-title":"Neurobiol. Dis."},{"key":"42876_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neuint.2018.03.001","volume":"117","author":"N Ammal Kaidery","year":"2018","unstructured":"Ammal Kaidery, N. & Thomas, B. Current perspective of mitochondrial biology in Parkinson\u2019s disease. Neurochem Int 117, 91\u2013113 (2018).","journal-title":"Neurochem Int"},{"key":"42876_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ncl.2014.09.010","volume":"33","author":"S Mullin","year":"2015","unstructured":"Mullin, S. & Schapira, A. H. Pathogenic mechanisms of neurodegeneration in Parkinson disease. Neurol. Clin. 33, 1\u201317 (2015).","journal-title":"Neurol. Clin."},{"key":"42876_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5607\/en.2014.23.4.345","volume":"23","author":"JY Han","year":"2014","unstructured":"Han, J. Y., Kim, J. S. & Son, J. H. Mitochondrial homeostasis molecules: regulation by a trio of recessive Parkinson\u2019s disease genes. Exp. Neurobiol. 23, 345\u2013351 (2014).","journal-title":"Exp. Neurobiol."},{"key":"42876_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/mds.25032","volume":"28","author":"EC Hirsch","year":"2013","unstructured":"Hirsch, E. C., Jenner, P. & Przedborski, S. Pathogenesis of Parkinson\u2019s disease. Mov. Disord. 28, 24\u201330 (2013).","journal-title":"Mov. Disord."},{"key":"42876_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106-107","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam, S. R. & Chesselet, M. F. Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog. Neurobiol. 106-107, 17\u201332 (2013).","journal-title":"Prog. Neurobiol."},{"key":"42876_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/rej.2005.8.3","volume":"8","author":"JJ Lemasters","year":"2005","unstructured":"Lemasters, J. J. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res 8, 3\u20135 (2005).","journal-title":"Rejuvenation Res"},{"key":"42876_CR10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.4161\/auto.5.5.8505","volume":"5","author":"D Narendra","year":"2009","unstructured":"Narendra, D., Tanaka, A., Suen, D. F. & Youle, R. J. Parkin-induced mitophagy in the pathogenesis of Parkinson disease. Autophagy 5, 706\u2013708 (2009).","journal-title":"Autophagy"},{"key":"42876_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1212\/01.wnl.0000167546.39375.82","volume":"65","author":"V Bonifati","year":"2005","unstructured":"Bonifati, V. et al. Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology 65, 87\u201395 (2005).","journal-title":"Neurology"},{"key":"42876_CR12","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1212\/01.WNL.0000164009.36740.4E","volume":"64","author":"Y Li","year":"2005","unstructured":"Li, Y. et al. Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism. Neurology 64, 1955\u20131957 (2005).","journal-title":"Neurology"},{"key":"42876_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1073\/pnas.0911187107","volume":"107","author":"C Vives-Bauza","year":"2010","unstructured":"Vives-Bauza, C. et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc. Natl. Acad. Sci. USA 107, 378\u2013383 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"42876_CR14","doi-asserted-by":"publisher","first-page":"e1000298","DOI":"10.1371\/journal.pbio.1000298","volume":"8","author":"DP Narendra","year":"2010","unstructured":"Narendra, D. P. et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 8, e1000298 (2010).","journal-title":"PLoS Biol."},{"key":"42876_CR15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","volume":"125","author":"AP Kiely","year":"2013","unstructured":"Kiely, A. P. et al. alpha-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson\u2019s disease and multiple system atrophy? Acta Neuropathol. 125, 753\u2013769 (2013).","journal-title":"Acta Neuropathol."},{"key":"42876_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz, J. J. et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164\u2013173 (2004).","journal-title":"Ann. Neurol."},{"key":"42876_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger, R. et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat. Genet 18, 106\u2013108 (1998).","journal-title":"Nat. Genet"},{"key":"42876_CR18","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. et al. Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276, 2045\u20132047 (1997).","journal-title":"Science"},{"key":"42876_CR19","doi-asserted-by":"publisher","first-page":"2180 e2181","DOI":"10.1016\/j.neurobiolaging.2014.03.024","volume":"35","author":"P Pasanen","year":"2014","unstructured":"Pasanen, P. et al. Novel alpha-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology. Neurobiol. Aging 35, 2180 e2181\u20132185 (2014).","journal-title":"Neurobiol. Aging"},{"key":"42876_CR20","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","volume":"80","author":"C Proukakis","year":"2013","unstructured":"Proukakis, C. et al. A novel alpha-synuclein missense mutation in Parkinson disease. Neurology 80, 1062\u20131064 (2013).","journal-title":"Neurology"},{"key":"42876_CR21","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","volume":"364","author":"P Ibanez","year":"2004","unstructured":"Ibanez, P. et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson\u2019s disease. Lancet 364, 1169\u20131171 (2004).","journal-title":"Lancet"},{"key":"42876_CR22","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton, A. B. et al. alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302, 841 (2003).","journal-title":"Science"},{"key":"42876_CR23","first-page":"546462","volume":"2015","author":"R Ferese","year":"2015","unstructured":"Ferese, R. et al. Four copies of SNCA responsible for autosomal dominant Parkinson\u2019s disease in Two Italian siblings. Parkinsons Dis. 2015, 546462 (2015).","journal-title":"Parkinsons Dis."},{"key":"42876_CR24","doi-asserted-by":"crossref","first-page":"342ra378","DOI":"10.1126\/scitranslmed.aaf3634","volume":"8","author":"R Di Maio","year":"2016","unstructured":"Di Maio, R. et al. alpha-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease. Sci. Transl. Med. 8, 342ra378 (2016).","journal-title":"Sci. Transl. Med."},{"key":"42876_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter, D. T. et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson\u2019s disease. J. Neurochem. 52, 381\u2013389 (1989).","journal-title":"J. Neurochem."},{"key":"42876_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/mds.870090115","volume":"9","author":"DT Dexter","year":"1994","unstructured":"Dexter, D. T. et al. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov. Disord. 9, 92\u201397 (1994).","journal-title":"Mov. Disord."},{"key":"42876_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/00005072-199804000-00006","volume":"57","author":"PF Good","year":"1998","unstructured":"Good, P. F., Hsu, A., Werner, P., Perl, D. P. & Olanow, C. W. Protein nitration in Parkinson\u2019s disease. J. Neuropathol. Exp. Neurol. 57, 338\u2013342 (1998).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"42876_CR28","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1046\/j.1471-4159.1997.69031326.x","volume":"69","author":"ZI Alam","year":"1997","unstructured":"Alam, Z. I. et al. A generalised increase in protein carbonyls in the brain in Parkinson\u2019s but not incidental Lewy body disease. J. Neurochem 69, 1326\u20131329 (1997).","journal-title":"J. Neurochem"},{"key":"42876_CR29","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0002-9440(10)65396-5","volume":"154","author":"J Zhang","year":"1999","unstructured":"Zhang, J. et al. Parkinson\u2019s disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 154, 1423\u20131429 (1999).","journal-title":"Am. J. Pathol."},{"key":"42876_CR30","first-page":"197","volume":"3","author":"RR Sanchez-Ramos","year":"1994","unstructured":"Sanchez-Ramos, R. R., Overvik, E. & Ames, B. N. A marker of oxyradical-mediated DNA damage (8-hydroxy-2\u2019-deoxyguanosine) is increased in nigra-striatum of Parkinson\u2019s disease. Neurodegeneration 3, 197\u2013204 (1994).","journal-title":"Neurodegeneration"},{"key":"42876_CR31","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/1531-8249(199912)46:6<920::AID-ANA17>3.0.CO;2-R","volume":"46","author":"H Shimura-Miura","year":"1999","unstructured":"Shimura-Miura, H. et al. Increased 8-oxo-dGTPase in the mitochondria of substantia nigral neurons in Parkinson\u2019s disease. Ann. Neurol. 46, 920\u2013924 (1999).","journal-title":"Ann. Neurol."},{"key":"42876_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ana.410380304","volume":"38","author":"MF Beal","year":"1995","unstructured":"Beal, M. F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38, 357\u2013366 (1995).","journal-title":"Ann. Neurol."},{"key":"42876_CR33","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1002\/ana.10483","volume":"53","author":"P Jenner","year":"2003","unstructured":"Jenner, P. Oxidative stress in Parkinson\u2019s disease. Ann. Neurol. 53, S26\u201336 (2003). Suppl 3discussion S36-28.","journal-title":"Ann. Neurol."},{"key":"42876_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuroscience.2020.04.032","volume":"437","author":"RB Creed","year":"2020","unstructured":"Creed, R. B. & Goldberg, M. S. Enhanced Susceptibility of PINK1 Knockout Rats to alpha-Synuclein Fibrils. Neuroscience 437, 64\u201375 (2020).","journal-title":"Neuroscience"},{"key":"42876_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/jnc.13266","volume":"139","author":"A Beilina","year":"2016","unstructured":"Beilina, A. & Cookson, M. R. Genes associated with Parkinson\u2019s disease: regulation of autophagy and beyond. J. Neurochem 139, 91\u2013107 (2016).","journal-title":"J. Neurochem"},{"key":"42876_CR36","doi-asserted-by":"crossref","unstructured":"Han, R., Liu, Y., Li, S., Li, X. J. & Yang, W. PINK1-PRKN mediated mitophagy: differences between in vitro and in vivo models. Autophagy 19, 1396\u20131405 (2023).","DOI":"10.1080\/15548627.2022.2139080"},{"key":"42876_CR37","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1093\/brain\/awac313","volume":"145","author":"D Imberechts","year":"2022","unstructured":"Imberechts, D. et al. DJ-1 is an essential downstream mediator in PINK1\/parkin-dependent mitophagy. Brain 145, 4368\u20134384 (2022).","journal-title":"Brain"},{"key":"42876_CR38","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1091\/mbc.e07-11-1103","volume":"19","author":"N Nakamura","year":"2008","unstructured":"Nakamura, N. & Hirose, S. Regulation of mitochondrial morphology by USP30, a deubiquitinating enzyme present in the mitochondrial outer membrane. Mol. Biol. Cell 19, 1903\u20131911 (2008).","journal-title":"Mol. Biol. Cell"},{"key":"42876_CR39","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature13418","volume":"510","author":"B Bingol","year":"2014","unstructured":"Bingol, B. et al. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature 510, 370\u2013375 (2014).","journal-title":"Nature"},{"key":"42876_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb3097","volume":"17","author":"CN Cunningham","year":"2015","unstructured":"Cunningham, C. N. et al. USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria. Nat. Cell Biol. 17, 160\u2013169 (2015).","journal-title":"Nat. Cell Biol."},{"key":"42876_CR41","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.molcel.2019.11.013","volume":"77","author":"A Ordureau","year":"2020","unstructured":"Ordureau, A. et al. Global landscape and dynamics of Parkin and USP30-dependent ubiquitylomes in iNeurons during mitophagic signaling. Mol. Cell 77, 1124\u20131142 e1110 (2020).","journal-title":"Mol. Cell"},{"key":"42876_CR42","doi-asserted-by":"publisher","first-page":"e202000768","DOI":"10.26508\/lsa.202000768","volume":"3","author":"EV Rusilowicz-Jones","year":"2020","unstructured":"Rusilowicz-Jones, E. V. et al. USP30 sets a trigger threshold for PINK1-PARKIN amplification of mitochondrial ubiquitylation. Life Sci. Alliance 3, e202000768 (2020).","journal-title":"Life Sci. Alliance"},{"key":"42876_CR43","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nsmb.3475","volume":"24","author":"M Gersch","year":"2017","unstructured":"Gersch, M. et al. Mechanism and regulation of the Lys6-selective deubiquitinase USP30. Nat. Struct. Mol. Biol. 24, 920\u2013930 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"42876_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JPD-201981","volume":"11","author":"M Borsche","year":"2021","unstructured":"Borsche, M., Pereira, S. L., Klein, C. & Grunewald, A. Mitochondria and Parkinson\u2019s disease: Clinical, molecular, and translational aspects. J. Parkinsons Dis. 11, 45\u201360 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"42876_CR45","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.molcel.2020.02.012","volume":"77","author":"L Phu","year":"2020","unstructured":"Phu, L. et al. Dynamic regulation of mitochondrial import by the ubiquitin system. Mol. Cell 77, 1107\u20131123 e1110 (2020).","journal-title":"Mol. Cell"},{"key":"42876_CR46","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1083\/jcb.201603039","volume":"214","author":"TG McWilliams","year":"2016","unstructured":"McWilliams, T. G. et al. mito-QC illuminates mitophagy and mitochondrial architecture in vivo. J. Cell Biol. 214, 333\u2013345 (2016).","journal-title":"J. Cell Biol."},{"key":"42876_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1750-1326-5-43","volume":"5","author":"JB Koprich","year":"2010","unstructured":"Koprich, J. B., Johnston, T. H., Reyes, M. G., Sun, X. & Brotchie, J. M. Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1\/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson\u2019s disease. Mol. Neurodegener. 5, 43 (2010).","journal-title":"Mol. Neurodegener."},{"key":"42876_CR48","doi-asserted-by":"publisher","first-page":"e0167235","DOI":"10.1371\/journal.pone.0167235","volume":"11","author":"JB Koprich","year":"2016","unstructured":"Koprich, J. B., Johnston, T. H., Reyes, G., Omana, V. & Brotchie, J. M. Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson\u2019s Disease: Optimization of AAV1\/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque. PLoS One 11, e0167235 (2016).","journal-title":"PLoS One"},{"key":"42876_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0416-x","volume":"5","author":"CW Ip","year":"2017","unstructured":"Ip, C. W. et al. AAV1\/2-induced overexpression of A53T-alpha-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson\u2019s disease. Acta Neuropathol. Commun. 5, 11 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"42876_CR50","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1007\/s12035-015-9173-7","volume":"53","author":"Q He","year":"2016","unstructured":"He, Q. et al. Treatment with trehalose prevents behavioral and neurochemical deficits produced in an AAV alpha-synuclein rat model of Parkinson\u2019s Disease. Mol. Neurobiol. 53, 2258\u20132268 (2016).","journal-title":"Mol. Neurobiol."},{"key":"42876_CR51","doi-asserted-by":"publisher","first-page":"e17698","DOI":"10.1371\/journal.pone.0017698","volume":"6","author":"JB Koprich","year":"2011","unstructured":"Koprich, J. B. et al. Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson\u2019s disease produced by decreasing doses of alpha-synuclein. PLoS One 6, e17698 (2011).","journal-title":"PLoS One"},{"key":"42876_CR52","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara, H. et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160\u2013164 (2002).","journal-title":"Nat. Cell Biol."},{"key":"42876_CR53","doi-asserted-by":"publisher","first-page":"113887","DOI":"10.1016\/j.bbr.2022.113887","volume":"429","author":"F Gubinelli","year":"2022","unstructured":"Gubinelli, F. et al. Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioral tests. Behav. Brain Res. 429, 113887 (2022).","journal-title":"Behav. Brain Res."},{"key":"42876_CR54","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/15548627.2015.1034408","volume":"11","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. Deubiquitinating enzymes regulate PARK2-mediated mitophagy. Autophagy 11, 595\u2013606 (2015).","journal-title":"Autophagy"},{"key":"42876_CR55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cub.2011.11.057","volume":"22","author":"V Soubannier","year":"2012","unstructured":"Soubannier, V. et al. A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. Curr. Biol. 22, 135\u2013141 (2012).","journal-title":"Curr. Biol."},{"key":"42876_CR56","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1113\/JP272703","volume":"594","author":"VJ Cadete","year":"2016","unstructured":"Cadete, V. J. et al. Formation of mitochondrial-derived vesicles is an active and physiologically relevant mitochondrial quality control process in the cardiac system. J. Physiol. 594, 5343\u20135362 (2016).","journal-title":"J. Physiol."},{"key":"42876_CR57","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41556-021-00798-4","volume":"23","author":"T Konig","year":"2021","unstructured":"Konig, T. et al. MIROs and DRP1 drive mitochondrial-derived vesicle biogenesis and promote quality control. Nat. Cell Biol. 23, 1271\u20131286 (2021).","journal-title":"Nat. Cell Biol."},{"key":"42876_CR58","doi-asserted-by":"crossref","unstructured":"Marcassa, E. et al. Dual role of USP30 in controlling basal pexophagy and mitophagy. EMBO Rep. 19, e45595 (2018).","DOI":"10.15252\/embr.201745595"},{"key":"42876_CR59","doi-asserted-by":"publisher","first-page":"eabe9977","DOI":"10.1126\/science.abe9977","volume":"374","author":"M Lisci","year":"2021","unstructured":"Lisci, M. et al. Mitochondrial translation is required for sustained killing by cytotoxic T cells. Science 374, eabe9977 (2021).","journal-title":"Science"},{"key":"42876_CR60","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1080\/15548627.2019.1656957","volume":"16","author":"K Niu","year":"2020","unstructured":"Niu, K. et al. USP33 deubiquitinates PRKN\/parkin and antagonizes its role in mitophagy. Autophagy 16, 724\u2013734 (2020).","journal-title":"Autophagy"},{"key":"42876_CR61","doi-asserted-by":"publisher","first-page":"e9014","DOI":"10.15252\/emmm.201809014","volume":"10","author":"J Chakraborty","year":"2018","unstructured":"Chakraborty, J. et al. USP14 inhibition corrects an in vivo model of impaired mitophagy. EMBO Mol. Med. 10, e9014 (2018).","journal-title":"EMBO Mol. Med."},{"key":"42876_CR62","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1093\/hmg\/ddu244","volume":"23","author":"T Cornelissen","year":"2014","unstructured":"Cornelissen, T. et al. The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy. Hum. Mol. Genet 23, 5227\u20135242 (2014).","journal-title":"Hum. Mol. Genet"},{"key":"42876_CR63","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/hmg\/ddy365","volume":"28","author":"X Liu","year":"2019","unstructured":"Liu, X., Hebron, M., Shi, W., Lonskaya, I. & Moussa, C. E. Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies. Hum. Mol. Genet 28, 548\u2013560 (2019).","journal-title":"Hum. Mol. Genet"},{"key":"42876_CR64","doi-asserted-by":"publisher","first-page":"8131","DOI":"10.3390\/ijms23158131","volume":"23","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. Inhibition of ubiquitin-specific protease-13 improves behavioral performance in alpha-synuclein expressing mice. Int J. Mol. Sci. 23, 8131 (2022).","journal-title":"Int J. Mol. Sci."},{"key":"42876_CR65","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose, A. & Beal, M. F. Mitochondrial dysfunction in Parkinson\u2019s disease. J. Neurochem 139, 216\u2013231 (2016).","journal-title":"J. Neurochem"},{"key":"42876_CR66","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-neuro-071013-014317","volume":"37","author":"NA Haelterman","year":"2014","unstructured":"Haelterman, N. A. et al. A mitocentric view of Parkinson\u2019s disease. Annu Rev. Neurosci. 37, 137\u2013159 (2014).","journal-title":"Annu Rev. Neurosci."},{"key":"42876_CR67","doi-asserted-by":"publisher","first-page":"592","DOI":"10.5483\/BMBRep.2021.54.12.107","volume":"54","author":"GH Park","year":"2021","unstructured":"Park, G. H., Park, J. H. & Chung, K. C. Precise control of mitophagy through ubiquitin proteasome system and deubiquitin proteases and their dysfunction in Parkinson\u2019s disease. BMB Rep. 54, 592\u2013600 (2021).","journal-title":"BMB Rep."},{"key":"42876_CR68","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/B978-0-444-63233-3.00014-2","volume":"147","author":"A Domingo","year":"2018","unstructured":"Domingo, A. & Klein, C. Genetics of Parkinson disease. Handb. Clin. Neurol. 147, 211\u2013227 (2018).","journal-title":"Handb. Clin. Neurol."},{"key":"42876_CR69","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","volume":"7","author":"AH Schapira","year":"2008","unstructured":"Schapira, A. H. Mitochondria in the aetiology and pathogenesis of Parkinson\u2019s disease. Lancet Neurol. 7, 97\u2013109 (2008).","journal-title":"Lancet Neurol."},{"key":"42876_CR70","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.brainres.2014.09.046","volume":"1591","author":"J Shen","year":"2014","unstructured":"Shen, J. et al. alpha-Synuclein amino terminus regulates mitochondrial membrane permeability. Brain Res. 1591, 14\u201326 (2014).","journal-title":"Brain Res."},{"key":"42876_CR71","doi-asserted-by":"publisher","first-page":"9089","DOI":"10.1074\/jbc.M710012200","volume":"283","author":"L Devi","year":"2008","unstructured":"Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G. & Anandatheerthavarada, H. K. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J. Biol. Chem. 283, 9089\u20139100 (2008).","journal-title":"J. Biol. Chem."},{"key":"42876_CR72","doi-asserted-by":"publisher","first-page":"e13175","DOI":"10.1111\/bpa.13175","volume":"33","author":"X Hou","year":"2023","unstructured":"Hou, X. et al. Alpha-synuclein-associated changes in PINK1-PRKN-mediated mitophagy are disease context dependent. Brain Pathol. 33, e13175 (2023).","journal-title":"Brain Pathol."},{"key":"42876_CR73","doi-asserted-by":"publisher","first-page":"20710","DOI":"10.1074\/jbc.M110.213538","volume":"286","author":"K Nakamura","year":"2011","unstructured":"Nakamura, K. et al. Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J. Biol. Chem. 286, 20710\u201320726 (2011).","journal-title":"J. Biol. Chem."},{"key":"42876_CR74","doi-asserted-by":"publisher","first-page":"10814","DOI":"10.1074\/jbc.M110.132514","volume":"286","author":"V Choubey","year":"2011","unstructured":"Choubey, V. et al. Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy. J. Biol. Chem. 286, 10814\u201310824 (2011).","journal-title":"J. Biol. Chem."},{"key":"42876_CR75","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","volume":"25","author":"ML Choi","year":"2022","unstructured":"Choi, M. L. et al. Pathological structural conversion of alpha-synuclein at the mitochondria induces neuronal toxicity. Nat. Neurosci. 25, 1134\u20131148 (2022).","journal-title":"Nat. Neurosci."},{"key":"42876_CR76","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1042\/BCJ20210508","volume":"478","author":"E Tsefou","year":"2021","unstructured":"Tsefou, E. et al. Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approaches. Biochem J. 478, 4099\u20134118 (2021).","journal-title":"Biochem J."},{"key":"42876_CR77","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1016\/j.bmcl.2018.05.013","volume":"28","author":"AF Kluge","year":"2018","unstructured":"Kluge, A. F. et al. Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy. Bioorg. Med. Chem. Lett. 28, 2655\u20132659 (2018).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"42876_CR78","doi-asserted-by":"publisher","first-page":"e202101287","DOI":"10.26508\/lsa.202101287","volume":"5","author":"EV Rusilowicz-Jones","year":"2022","unstructured":"Rusilowicz-Jones, E. V. et al. Benchmarking a highly selective USP30 inhibitor for enhancement of mitophagy and pexophagy. Life Sci. Alliance 5, e202101287 (2022).","journal-title":"Life Sci. Alliance"},{"key":"42876_CR79","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/hep.31249","volume":"73","author":"L Gu","year":"2021","unstructured":"Gu, L. et al. The IKKbeta-USP30-ACLY axis controls lipogenesis and tumorigenesis. Hepatology 73, 160\u2013174 (2021).","journal-title":"Hepatology"},{"key":"42876_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"42876_CR81","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuroscience.2020.01.006","volume":"429","author":"NJ Morriss","year":"2020","unstructured":"Morriss, N. J. et al. Automated quantification of immunohistochemical staining of large animal brain tissue using QuPath software. Neuroscience 429, 235\u2013244 (2020).","journal-title":"Neuroscience"},{"key":"42876_CR82","doi-asserted-by":"publisher","first-page":"ENEURO.0177","DOI":"10.1523\/ENEURO.0177-21.2021","volume":"8","author":"JM Courtney","year":"2021","unstructured":"Courtney, J. M., Morris, G. P., Cleary, E. M., Howells, D. W. & Sutherland, B. A. An automated approach to improve the quantification of pericytes and microglia in whole mouse brain sections. eNeuro 8, ENEURO.0177\u201321 (2021).","journal-title":"eNeuro"},{"key":"42876_CR83","doi-asserted-by":"crossref","unstructured":"Ip, C. W., Cheong, D. & Volkmann, J. Stereological estimation of dopaminergic neuron number in the mouse substantia nigra using the optical fractionator and standard microscopy equipment. J. Vis. Exp. 127, 56103 (2017).","DOI":"10.3791\/56103-v"},{"key":"42876_CR84","doi-asserted-by":"publisher","unstructured":"Chin, R. M. et al. Pharmacological PINK1 activation ameliorates Pathology in Parkinson\u2019s Disease models. bioRxiv https:\/\/doi.org\/10.1101\/2023.02.14.528378 (2023).","DOI":"10.1101\/2023.02.14.528378"},{"key":"42876_CR85","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1083\/jcb.201804172","volume":"218","author":"V Riccio","year":"2019","unstructured":"Riccio, V. et al. Deubiquitinating enzyme USP30 maintains basal peroxisome abundance by regulating pexophagy. J. Cell Biol. 218, 798\u2013807 (2019).","journal-title":"J. Cell Biol."},{"key":"42876_CR86","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13293-014-0015-5","volume":"5","author":"LD McCullough","year":"2014","unstructured":"McCullough, L. D. et al. NIH initiative to balance sex of animals in preclinical studies: generative questions to guide policy, implementation, and metrics. Biol. Sex. Differ. 5, 15 (2014).","journal-title":"Biol. Sex. Differ."},{"key":"42876_CR87","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1096\/fj.15-279554","volume":"30","author":"JA Clayton","year":"2016","unstructured":"Clayton, J. A. Studying both sexes: a guiding principle for biomedicine. FASEB J. 30, 519\u2013524 (2016).","journal-title":"FASEB J."},{"key":"42876_CR88","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1096\/fj.201600781r","volume":"31","author":"LR Miller","year":"2017","unstructured":"Miller, L. R. et al. Considering sex as a biological variable in preclinical research. FASEB J. 31, 29\u201334 (2017).","journal-title":"FASEB J."},{"key":"42876_CR89","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.cell.2013.06.022","volume":"154","author":"JK White","year":"2013","unstructured":"White, J. K. et al. Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes. Cell 154, 452\u2013464 (2013).","journal-title":"Cell"},{"key":"42876_CR90","doi-asserted-by":"publisher","first-page":"e1002151","DOI":"10.1371\/journal.pbio.1002151","volume":"13","author":"NA Karp","year":"2015","unstructured":"Karp, N. A. et al. Applying the ARRIVE guidelines to an in vivo database. PLoS Biol. 13, e1002151 (2015).","journal-title":"PLoS Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42876-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42876-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42876-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T06:02:06Z","timestamp":1699855326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42876-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42876"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-42876-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"assertion":[{"value":"16 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.C.P., M.K., C.A.L., R.W., R.M., S.A., L.B. and N.M. and P.T. are employees of, or former employees of, Mission therapeutics. S.J. is a founder, shareholder and board member of Mission Therapeutics. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7295"}}